SCHEMBL20115437

SCHEMBL20115437

CNC(=O)c1ccc(-c2ccc(/C=N/NC(=S)NN)o2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PHGDH O43175 7/20 0.77
MAPT P10636 5/20 0.71
NPC1 O15118 4/20 0.71
KDM4E B2RXH2 4/20 0.71
PKM P14618 2/20 0.71
POLB P06746 1/20 0.71
HSP90AA1 P07900 1/20 0.71
APEX1 P27695 1/20 0.71
TDP1 Q9NUW8 1/20 0.71
L3MBTL1 Q9Y468 1/20 0.71
RAB9A P51151 3/20 0.57
KEAP1 Q14145 1/20 0.56
NFE2L2 Q16236 1/20 0.56
NPSR1 Q6W5P4 1/20 0.55
ALDH1A1 P00352 2/20 0.53
LMNA P02545 2/20 0.52
PRMT5 O14744 1/20 0.52
WDR77 Q9BQA1 1/20 0.52
HPGD P15428 1/20 0.52
ALOX12 P18054 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21292829 1.00 PHGDH (0.77) PHGDHMAPTNPC1KDM4EPKM
SCHEMBL28373708 0.88 KEAP1 (0.65) PHGDHMAPTNPC1KDM4EPKM
SCHEMBL28373709 0.88 KEAP1 (0.65) PHGDHMAPTNPC1KDM4EPKM
SCHEMBL21292822 0.87 PHGDH (1.00) PHGDHMAPTNPC1KDM4EPKM
SCHEMBL20115432 0.87 PHGDH (1.00) PHGDHMAPTNPC1KDM4EPKM
SCHEMBL20115436 0.86 PHGDH (1.00) PHGDHMAPTNPC1KDM4EPKM
SCHEMBL21292826 0.83 KDM4E (1.00) PHGDHMAPTNPC1KDM4EPKM
SCHEMBL21292824 0.83 KDM4E (1.00) PHGDHMAPTNPC1KDM4EPKM
SCHEMBL20115433 0.82 PHGDH (0.80) PHGDHMAPTNPC1KDM4EPKM
SCHEMBL20115435 0.82 PHGDH (0.80) PHGDHMAPTNPC1KDM4EPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof PEKING UNIVERSITY (CN) 2020-07-28 US disclosed
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof PEKING UNIVERSITY (CN) 2020-07-28 US disclosed
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2020-02-20 US disclosed
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2020-02-20 US disclosed
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2019-08-29 US disclosed
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2019-08-29 US disclosed
WO-2018076537-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF 北京大学 2018-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof MDH2, MDH1, DLD PHGDH 4/4885MAPT 3785/4885NPC1 4801/4885
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD PHGDH 4/4885MAPT 3785/4885NPC1 4801/4885
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD PHGDH 4/4885MAPT 3785/4885NPC1 4801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.